Kévin Ly

Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial

Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells

TREM2 Binds to Apolipoproteins, Including APOE and CLU/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia

<div>Lipid nanoparticles for targeted siRNA delivery &ndash; going from bench to bedside</div>

Non-viral vectors for gene-based therapy

Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors

In vivo genome editing using Staphylococcus aureus Cas9

Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer

Mechanisms and regulation of cholesterol homeostasis

Degradation from the outside in: Targeting extracellular and membrane proteins for degradation through the endolysosomal pathway

Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials

Spontaneous Light Emission Assisted by Mie Resonances in Diamond Nanoparticles

Highly Fluorescent Nanodiamonds Protein‐Functionalized for Cell Labeling and Targeting

Targeting PCSK9 for Hypercholesterolemia

Microglia Function in the Central Nervous System During Health and Neurodegeneration

DAMP-sensing receptors in sterile inflammation and inflammatory diseases

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

Self-programmed nanovesicle to nanofiber transformation of a dipeptide appended bolaamphiphile and its dose dependent cytotoxic behaviour

Dissection of the Endogenous Cellular Pathways of PCSK9-induced Low Density Lipoprotein Receptor Degradation

Design, Synthesis, and Structure–Activity Relationship Studies of a Potent PACE4 Inhibitor